Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001068238-24-000192
Filing Date
2024-09-27
Accepted
2024-09-27 21:36:39
Documents
1
Group Members
YEKATERINA CHUDNOVSKY

Document Format Files

Seq Description Document Type Size
1 GKCC SCHEDULE 13G gkcc_sch13g.htm SC 13G 53166
  Complete submission text file 0001068238-24-000192.txt   54718
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Subject) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92962 | Film No.: 241336367
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809
Business Address 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809 (302) 992-8882
GKCC, LLC (Filed by) CIK: 0001977769 (see all company filings)

EIN.: 472175589 | State of Incorp.: DE
Type: SC 13G